InsiderClue

Insider trading

Period: 120 months Stock: LFCR Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
When Periodin use
Who Role
The trade Type of trade Minimum amountin use Plan Share of their own holding
Ownership What the chief executive holds
When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

1 month 12 months 120 months
41 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

Anyone CEO CFO Other officers Directors 10% owners
41 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

Any41 Buys27 Sells14 Cluster buys
41 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

Any $100K or more $1M or more $10M or more $100M or more $500M or more
41 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
Any Discretionary Scheduled (10b5-1) Not stated Not on a plan
41 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
41 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

41 decisions over 120 months
Stock
Insider
Type ?
Value ↓
Of own stake ↓
Why it stands out
LFCR LIFECORE BIOMEDICAL, INC. DE
28 May 2025
English Aron R. 10% owner · indirect
Sold at will
$1.07M 150,419 at 7.12
36.3%
Not planned
LFCR LIFECORE BIOMEDICAL, INC. DE
27 May 2025
English Aron R. 10% owner · indirect
Sold at will
$7.41M 1,139,504 at 6.50
73.3%
Sold half or more
LFCR LIFECORE BIOMEDICAL, INC. DE
23 May 2025
English Aron R. 10% owner · indirect
Sold at will
$649.39K 96,137 at 6.75
5.8%
Not planned
LFCR LIFECORE BIOMEDICAL, INC. DE
12 May 2025
English Aron R. 10% owner · indirect
Sold at will
$321.43K 45,698 at 7.03
2.7%
Not planned
LFCR LIFECORE BIOMEDICAL, INC. DE
7 May 2025
English Aron R. 10% owner · indirect
Sold at will
$111.10K 15,847 at 7.01
0.9%
Not planned
LFCR LIFECORE BIOMEDICAL, INC. DE
5 May 2025
English Aron R. 10% owner · indirect
Sold at will
$173.83K 24,543 at 7.08
1.4%
Not planned
LFCR LIFECORE BIOMEDICAL, INC. DE
3 Oct 2024
Kiper Christopher S Director · indirect
Bought 2×
$6.00M 1,463,414 at 4.10
55.8%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
3 Oct 2024
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner · indirect
Bought
$695.99K 169,753 at 4.10
7.0%
LFCR LIFECORE BIOMEDICAL, INC. DE
3 Oct 2024
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner
Bought
$504.01K 122,930 at 4.10
6.2%
LFCR LIFECORE BIOMEDICAL, INC. DE
25 Nov 2022
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner
Bought
$2.75M 345,260 at 7.97
21.2%
Largest buy in 3 yrs
LFCR LIFECORE BIOMEDICAL, INC. DE
25 Nov 2022
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner · indirect
Bought
$2.25M 282,486 at 7.97
13.1%
Largest buy in 3 yrs
LFCR LIFECORE BIOMEDICAL, INC. DE
24 Oct 2022
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner · indirect
Bought
$1.19M 147,000 at 8.09
7.3%
LFCR LIFECORE BIOMEDICAL, INC. DE
24 Oct 2022
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner
Bought
$833.27K 103,000 at 8.09
6.8%
LFCR LIFECORE BIOMEDICAL, INC. DE
13 Jan 2022
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner · indirect
Bought 2×
$554.83K 53,280 at 10.41
2.7%
LFCR LIFECORE BIOMEDICAL, INC. DE
13 Jan 2022
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner
Bought 2×
$355.31K 34,120 at 10.41
2.3%
LFCR LIFECORE BIOMEDICAL, INC. DE
12 Jan 2022
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner · indirect
Bought
$2.18M 209,872 at 10.41
12.0%
Largest buy in 3 yrs
LFCR LIFECORE BIOMEDICAL, INC. DE
12 Jan 2022
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner
Bought
$937.96K 90,128 at 10.41
6.4%
LFCR LIFECORE BIOMEDICAL, INC. DE
20 Apr 2021
Walsh Patrick D Director
Bought
$112.60K 10,000 at 11.26
33.3%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
14 Apr 2021
Hall James G Vice President
Bought
$106.20K 10,000 at 10.62
34.3%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
12 Apr 2021
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner · indirect
Bought
$1.66M 165,564 at 10.02
10.5%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
12 Apr 2021
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10% owner
Bought
$726.45K 72,515 at 10.02
5.5%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
19 Jan 2021
Bolles Albert D. Chief Executive Officer
Bought
$109.80K 10,000 at 10.98
38.2%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
12 Jan 2021
OBUS NELSON Director · indirect
Bought
$146.06K 13,600 at 10.74
0.5%
Largest buy in 3 yrs
LFCR LIFECORE BIOMEDICAL, INC. DE
5 Nov 2019
OBUS NELSON Director · indirect
Bought
$103.80K 10,000 at 10.38
0.3%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
5 Aug 2019
OBUS NELSON Director · indirect
Bought
$105.00K 10,000 at 10.50
0.4%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
2 Aug 2019
OBUS NELSON Director · indirect
Bought
$214.40K 20,000 at 10.72
0.7%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
10 Apr 2019
OBUS NELSON Director · indirect
Bought
$309.90K 30,000 at 10.33
1.1%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
9 Apr 2019
OBUS NELSON Director · indirect
Bought
$102.40K 10,000 at 10.24
0.4%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
8 Apr 2019
OBUS NELSON Director · indirect
Bought
$207.60K 20,000 at 10.38
0.7%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
6 Feb 2019
OBUS NELSON Director · indirect
Bought
$247.60K 20,000 at 12.38
0.7%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
10 Jan 2019
OBUS NELSON Director · indirect
Bought
$226.60K 20,000 at 11.33
0.7%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
8 Jan 2019
SKINNER GREGORY S Chief Financial Officer
Bought
$281.25K 25,000 at 11.25
9.5%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
8 Jan 2019
GOLDBY STEVEN D Director
Bought
$224.80K 20,000 at 11.24
43.0%
First buy on file
LFCR LIFECORE BIOMEDICAL, INC. DE
9 May 2018
Midyett Ronald Lane Chief Operations Officer
Sold, plan not stated
$123.43K 9,239 at 13.36
13.6%
LFCR LIFECORE BIOMEDICAL, INC. DE
18 Apr 2018
Midyett Ronald Lane Chief Operations Officer
Sold, plan not stated
$169.53K 12,179 at 13.92
14.3%
LFCR LIFECORE BIOMEDICAL, INC. DE
10 May 2017
STEELE GARY T Director · indirect
Sold, plan not stated 2×
$747.82K 53,416 at 14.00
39.2%
LFCR LIFECORE BIOMEDICAL, INC. DE
11 Apr 2017
Midyett Ronald Lane Chief Operations Officer
Sold, plan not stated
$275.20K 20,000 at 13.76
19.1%
LFCR LIFECORE BIOMEDICAL, INC. DE
7 Apr 2017
BITLER STEVEN P Vice President, Technology · indirect
Sold, plan not stated
$108.64K 8,000 at 13.58
10.3%
LFCR LIFECORE BIOMEDICAL, INC. DE
31 Jan 2017
HIEBERT LARRY D Executive Vice President
Sold, plan not stated
$147.35K 11,704 at 12.59
100%
Sold half or more
LFCR LIFECORE BIOMEDICAL, INC. DE
11 Nov 2016
SKINNER GREGORY S VP Finance and Admin & CFO
Sold, plan not stated
$548.89K 39,214 at 14.00
16.4%
LFCR LIFECORE BIOMEDICAL, INC. DE
10 Nov 2016
SKINNER GREGORY S VP Finance and Admin & CFO
Sold, plan not stated
$150.60K 10,786 at 13.96
4.3%
Showing 1–41 of 41.